VW
IBB icon

Vance Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Vance Wealth’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$262K Hold
1,552
– – 0.08% 103
2025
Q4 		$262K Hold
1,552
– – 0.08% 100
2025
Q3 		$224K Buy
+1,552
New +$212K 0.07% 109
2023
Q2 		– Sell
-1,803
Closed -$233K – 82
2023
Q1 		$233K Hold
1,803
– – 0.13% 65
2022
Q4 		$237K Sell
1,803
-100
-5% -$12.9K 0.15% 65
2022
Q3 		$223K Buy
+1,903
New +$236K 0.17% 59
2022
Q1 		– Sell
-1,943
Closed -$297K – 62
2021
Q4 		$297K Buy
+1,943
New +$301K 0.29% 46

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Vance Wealth's IBB Position: Q1 2026 in Review

Vance Wealth held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 1,552 shares worth $262K. The position accounts for 0.08% of the portfolio, ranked #103.

Vance Wealth first reported a position in IBB in Q4 2021 and has held it in 7 quarters since. The position peaked at $297K in Q4 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Vance Wealth held 1,552 shares of iShares Biotechnology ETF worth $262K as of Q1 2026.
  • Vance Wealth left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up 0.08% of Vance Wealth's portfolio in Q1 2026, its #103 holding.
  • Vance Wealth first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 7 quarters since.
  • Vance Wealth's iShares Biotechnology ETF position peaked at $297K in Q4 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Vance Wealth's 13F filing for Q1 2026, filed 15 May 2026.